Bank of New York Mellon Corp Has $1.15 Million Stock Position in Quanterix Co. (NASDAQ:QTRX)

Bank of New York Mellon Corp boosted its position in Quanterix Co. (NASDAQ:QTRX) by 1.8% during the 4th quarter, Holdings Channel reports. The fund owned 108,186 shares of the company’s stock after buying an additional 1,963 shares during the period. Bank of New York Mellon Corp’s holdings in Quanterix were worth $1,150,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Graypoint LLC acquired a new position in shares of Quanterix during the fourth quarter worth approximately $691,000. Algert Global LLC increased its stake in Quanterix by 75.9% during the 3rd quarter. Algert Global LLC now owns 137,833 shares of the company’s stock valued at $1,786,000 after purchasing an additional 59,496 shares in the last quarter. Geode Capital Management LLC raised its holdings in Quanterix by 2.2% during the third quarter. Geode Capital Management LLC now owns 858,667 shares of the company’s stock worth $11,131,000 after buying an additional 18,231 shares during the last quarter. Barclays PLC raised its holdings in Quanterix by 42.3% during the third quarter. Barclays PLC now owns 146,248 shares of the company’s stock worth $1,896,000 after buying an additional 43,447 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Quanterix by 28.1% in the third quarter. JPMorgan Chase & Co. now owns 217,957 shares of the company’s stock valued at $2,825,000 after buying an additional 47,873 shares in the last quarter. Institutional investors and hedge funds own 86.48% of the company’s stock.

Quanterix Stock Down 0.4 %

Shares of NASDAQ:QTRX opened at $7.19 on Tuesday. The stock has a market cap of $278.80 million, a price-to-earnings ratio of -6.78 and a beta of 1.33. The business’s 50 day moving average is $8.15 and its 200 day moving average is $10.78. Quanterix Co. has a 12-month low of $6.30 and a 12-month high of $24.05.

Quanterix (NASDAQ:QTRX) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.03). The firm had revenue of $35.16 million for the quarter, compared to analysts’ expectations of $34.93 million. Quanterix had a negative return on equity of 11.74% and a negative net margin of 30.12%. As a group, equities research analysts expect that Quanterix Co. will post -0.98 earnings per share for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group decreased their target price on shares of Quanterix from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th.

Quanterix Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.